Am J Cardiol

1. SIBY A, Hashemzadeh M, Movahed MR
   Higher mortality in male patients with Takotsubo cardiomyopathy appears to be related to higher complication rates.
   Am J Cardiol. 2025 Nov 25:S0002-9149(25)00698.
   

   >> Share

   
   

   
   Am J Emerg Med

2. THABOUILLOT O, Rozenberg E, Corcostegui SP, Derkenne C, et al
   Surviving ventricular fibrillation: A documented Lazarus phenomenon.
   Am J Emerg Med. 2025;101:110-113.
   

   >> Share

   
   

   
   Ann Intern Med

3. RUZIEH M
   In adults at high risk for ventricular arrhythmia, treatment to increase potassium to high-normal levels improved a composite outcome.
   Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-04843.
   

   >> Share

   
   

   
   Eur Heart J

4. XIE D, Liang D, Zhou L, Liu Y, et al
   Cardiac endogenous transmitter system: molecular features, functions, and clinical implications.
   Eur Heart J. 2026;47:188-198.
   

   >> Share

   
   
5. VAD OB, van Vreeswijk N, Yassin AS, Blaauw Y, et al
   Atrial cardiomyopathy: markers and outcomes.
   Eur Heart J. 2025 Oct 15:ehaf793. doi: 10.1093.
   

   >> Share

   
   
6. FINOCCHIARO G, Zorzi A, Abela M, Baggish A, et al
   Abnormal electrocardiogram findings in athletes.
   Eur Heart J. 2026;47:152-169.
   

   >> Share

   
   
7. PERETTO G, Merlo M, Ambrosi A, Bacigalupi E, et al
   Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score.
   Eur Heart J. 2026;47:94-106.
   

   >> Share

   
   
8. LOWRES N, Orchard JJ, Freedman B
   Digital heartbeat: wearables for early detection and integrated management of atrial fibrillation.
   Eur Heart J. 2026 Jan 8:ehaf998. doi: 10.1093.
   

   >> Share

   
   
9. CREA F
   Focus on arrhythmias: cardiac endogenous transmitter systems, atrial fibrillation, and short QT and Brugada syndromes.
   Eur Heart J. 2026;47:139-144.
   

   >> Share

   
   

   
   J Cardiol

10. YAGINUMA H, Kitahara H, Suzuki S, Ohno Y, et al
    Prognostic impact of chronic kidney disease in patients with atrial fibrillation after percutaneous coronary intervention.
    J Cardiol. 2026 Jan 6:S0914-5087(25)00323-5. doi: 10.1016/j.jjcc.2025.
    

    >> Share

    
    

    
    J Cardiovasc Electrophysiol

11. XIE HY, Chen Y, Xie Y, Wu J, et al
    A Simple Method Is Used to Identify PVI-Responsive Patients With Persistent Atrial Fibrillation: Electrical Cardioversion and Noninduction Before Procedure.
    J Cardiovasc Electrophysiol. 2026 Jan 9. doi: 10.1111/jce.70240.
    

    >> Share

    
    
12. HARADA M, Motoike Y, Nomura Y, Nishimura A, et al
    Averaged Impedance Drop Estimates Conduction Gap During Pulmonary Vein Isolation in Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2026 Jan 9. doi: 10.1111/jce.70246.
    

    >> Share

    
    

    
    J Interv Card Electrophysiol

13. KOZAILY E, Dhakal BP, Laxina I, Dowd RP, et al
    Rescue upon rescue: ventricular tachycardia ablation using cerebral protection device in a patient with left ventricular thrombus associated with mitral valve transcatheter repair.
    J Interv Card Electrophysiol. 2026;69:11-14.
    

    >> Share

    
    
14. SABATELLI L, Silvetti G, Giacomini G, Compagnucci P, et al
    Fascicular tachycardia ablation using optrell mapping catheter: a case report.
    J Interv Card Electrophysiol. 2026;69:5-9.
    

    >> Share

    
    
15. HAJ ABDO M, Deneke T, Nentwich K, Chakarov I, et al
    Gastroparesis as a potential complication of pentaspline pulsed field ablation without endoscopic esophageal injury.
    J Interv Card Electrophysiol. 2026;69:63-69.
    

    >> Share

    
    
16. BARBOSA LM, Mazetto R, Defante MLR, Antunes VLJ, et al
    A systematic review and meta-analysis of artificial intelligence ECGs performance in the diagnosis of Brugada Syndrome.
    J Interv Card Electrophysiol. 2026;69:25-34.
    

    >> Share

    
    
17. KILIC ME, Turan OE, Yilancioglu RY, Ozcan EE, et al
    GLP-1 receptor agonist therapy is associated with reduced atrial fibrillation recurrence after catheter ablation: a meta-analysis.
    J Interv Card Electrophysiol. 2026 Jan 6. doi: 10.1007/s10840-025-02233.
    

    >> Share

    
    
18. KSAYER R, Younes H, Tsakiris E, Perez BG, et al
    Pre-ablation rate control therapy and direct-to-catheter ablation in patients with persistent atrial fibrillation: A DECAAF II subanalysis.
    J Interv Card Electrophysiol. 2026 Jan 6. doi: 10.1007/s10840-025-02218.
    

    >> Share

    
    
19. KATO H, Yanagisawa S, Morishima I, Kanzaki Y, et al
    Comparison of left bundle branch area pacing and biventricular pacing for atrioventricular block with heart failure and mild-to-moderately reduced left ventricular systolic function: design and rationale of the BLOCK NAGOYA randomized clinical trial.
    J Interv Card Electrophysiol. 2026 Jan 2. doi: 10.1007/s10840-025-02210.
    

    >> Share

    
    
20. PATIL S, Siontis KC
    First-in-human use of the dual-energy SMARTTOUCH SF radiofrequency and pulsed field ablation catheter for ventricular arrhythmia treatment.
    J Interv Card Electrophysiol. 2026 Jan 2. doi: 10.1007/s10840-025-02219.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share